Asset Details
Do you wish to reserve the book?
The Future of Treatment for Wet AMD
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Future of Treatment for Wet AMD
Do you wish to request the book?
The Future of Treatment for Wet AMD
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Future of Treatment for Wet AMD
2017
Overview
Purpose of Review
Age-related macular degeneration is among the leading causes of blindness in the USA, and the prevalence is increasing. Although anti-vascular endothelial growth factor (VEGF) therapy has dramatically improved the treatment outcome for patients with wet age-related macular degeneration (AMD), repeated intravitreal injections can be a challenge for patients and physicians. The following provides a review of several innovative approaches to wet AMD therapy currently under investigation.
Recent Findings
Novel anti-VEGF delivery routes, platelet-derived growth factor (PDGF) receptor antagonism, immunomodulatory therapy, and new imaging technology are all poised to possibly expand the current clinical options available for wet AMD patients.
Summary
There are a number of exciting new treatment modalities for wet AMD currently being researched. As clinical trials of these new therapies continue, we can hope that improved visual outcomes and patient satisfaction are on the horizon.
Publisher
Springer US,Springer Nature B.V
